{"id": "1339599754989203456", "creation": 1608220444.0, "user_id": "1048559226124087296", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 2, "like_count": 18, "quote_count": 0}}, "text": "Undeservedly privileged to be able to enroll in the #Phase4 study of the @BioNTech_Group #COVID19 #vaccine. Hoping this #mRNA technology will be successful with an #HIV vaccine (p24 target?) and that this will become a #PeoplesVaccine accessible to all. @PIDSociety @IDSAInfo https://t.co/f5y4nvnzOK", "first_save": 1634559108.199414, "geo": "07d9db044d482000", "hashtags": ["#PHASE4", "#COVID19", "#VACCINE", "#MRNA", "#HIV", "#PEOPLESVACCINE"]}